Want to join the conversation?
As per the new collaboration agreement for metabolic immuno-oncology programs, $CELG and $AGIO said that the companies will share the cost and profit with a mix of 50/50. $AGIO is eligible for up to $169MM in clinical and regulatory milestone payments for each program. $CELG will lead ex-U.S. development and commercialization for all programs.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!